Penalty Amount
$29,600,000
Attorney General Jennifer Davenport joined a coalition of 48 states and territories in a $29.6 million settlement with Glenmark, a generic drug manufacturer, for allegedly conspiring to artificially inflate and manipulate prices, reduce competition, and restrain trade for numerous generic prescription drugs. The settlement includes cooperation in ongoing litigations and internal reforms to ensure fair competition.
Glenmark will pay $29.6 million, cooperate in ongoing multistate litigations against 33 corporate defendants and 25 individual executives, and implement internal reforms to ensure fair competition and compliance with antitrust laws.
In-house legal teams should review vendor agreements with pharmaceutical manufacturers and distributors for any clauses related to pricing, market allocation, or information sharing that could facilitate collusion. Customer agreements should be examined for pricing terms and any provisions that might restrict competition. Employee contracts and non-disclosure agreements should be checked for compliance with antitrust laws and cooperation obligations.
Entity
Glenmark
Industry
PharmaceuticalOfficial Press Release
https://www.njoag.gov/attorney-general-davenport-announces-29-6-million-multistate-settlement-with-glenmark-for-widespread-conspiracy-to-overcharge-patients-for-prescriptions-and-suppress-competition/
aurobindo pharma usa inc et al settlement agreement 2026
https://www.njoag.gov/wp-content/uploads/2026/07/aurobindo-pharma-usa-inc-et-al-settlement-agreement-2026.pdf
Connecticut Attorney General Enforcement Page
https://portal.ct.gov/AG/Privacy/Privacy-Resources
"Glenmark"
"$29.6 million settlement"
"antitrust laws"
"artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade"
"coalition of 48 states and territories"
"internal reforms to ensure fair competition and compliance with antitrust laws"
$29.6M
Attorney General William Tong led a coalition of 48 states and territories in a $29.6 million settlement with Glenmark, a generic drug manufacturer, to resolve allegations of a widespread conspiracy to artificially inflate prices, reduce competition, and unreasonably restrain trade for numerous generic prescription drugs. The settlement includes cooperation from Glenmark in ongoing multistate litigations and internal reforms to ensure fair competition and compliance with antitrust laws.
$625K
Connecticut reached a $625,000 settlement with Frontier Communications Parent Inc. over an April 2024 breach in which compromised employee and vendor credentials were used to access internal systems and exfiltrate unencrypted personal information of 58,841 Connecticut residents. The settlement requires Frontier to strengthen its security program, implement specific safeguards and training, and obtain an independent third-party assessment.
$2.6M
Connecticut and New York found that Boston Children’s Health Physicians and its security vendor, XTIUM, failed to use reasonable safeguards, resulting in hackers accessing sensitive personal, medical, and employee information. The companies agreed to pay penalties totaling $2.64 million and implement enhanced cybersecurity measures.
Connecticut joined a coalition of state attorneys general filing a notice in Character Technologies, Inc.’s bankruptcy proceedings, raising concerns about the company’s safety and privacy practices and the sensitive information it holds. The states seek protections for children and consumers if the company’s business or assets are sold or transferred; the filing does not impose a fine or other remedy.
Attorney General William Tong and Consumer Counsel Claire Coleman petitioned PURA to review how Connecticut public utilities use artificial intelligence, citing potential data privacy and cybersecurity risks, algorithmic errors, and misleading outputs. The petition asks PURA to examine utility AI systems, safeguards, vendors, and data security practices; it does not report a finding of violation or an imposed penalty.
$2.0M
Connecticut Attorney General William Tong announced a settlement with RZ Smoke, Inc. over allegations that it distributed and sold high-potency cannabis products without a state license. The stipulated judgment is $2 million, with $375,000 payable to the State and $1.6 million suspended to ensure compliance; the company is barred from specified cannabis activities in Connecticut unless licensed.